Literature DB >> 21911804

Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses.

Robert L Lobato1, William D White, Joseph P Mathew, Mark F Newman, Peter K Smith, Charles B McCants, John H Alexander, Mihai V Podgoreanu.   

Abstract

BACKGROUND: We tested the hypothesis that genetic variation in thrombotic and inflammatory pathways is independently associated with long-term mortality after coronary artery bypass graft (CABG) surgery. METHODS AND
RESULTS: Two separate cohorts of patients undergoing CABG surgery at a single institution were examined, and all-cause mortality between 30 days and 5 years after the index CABG was ascertained from the National Death Index. In a discovery cohort of 1018 patients, a panel of 90 single-nucleotide polymorphisms (SNPs) in 49 candidate genes was tested with Cox proportional hazard models to identify clinical and genomic multivariate predictors of incident death. After adjustment for multiple comparisons and clinical predictors of mortality, the homozygote minor allele of a common variant in the thrombomodulin (THBD) gene (rs1042579) was independently associated with significantly increased risk of all-cause mortality (hazard ratio, 2.26; 95% CI, 1.31 to 3.92; P=0.003). Six tag SNPs in the THBD gene, 1 of which (rs3176123) in complete linkage disequilibrium with rs1042579, were then assessed in an independent validation cohort of 930 patients. After multivariate adjustment for the clinical predictors identified in the discovery cohort and multiple testing, the homozygote minor allele of rs3176123 independently predicted all-cause mortality (hazard ratio, 3.6; 95% CI, 1.67 to 7.78; P=0.001).
CONCLUSIONS: In 2 independent cardiac surgery cohorts, linked common allelic variants in the THBD gene are independently associated with increased long-term mortality risk after CABG and significantly improve the classification ability of traditional postoperative mortality prediction models.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911804      PMCID: PMC3192987          DOI: 10.1161/CIRCULATIONAHA.110.008334

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Selecting SNPs in two-stage analysis of disease association data: a model-free approach.

Authors:  J Hoh; A Wille; R Zee; S Cheng; R Reynolds; K Lindpaintner; J Ott
Journal:  Ann Hum Genet       Date:  2000-09       Impact factor: 1.670

2.  Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease.

Authors:  Kenneth K Wu; Nena Aleksic; Christie M Ballantyne; Chul Ahn; Harinder Juneja; Eric Boerwinkle
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

3.  Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery.

Authors:  Samer A M Nashef; Francois Roques; Bradley G Hammill; Eric D Peterson; Philippe Michel; Frederick L Grover; Richard K H Wyse; T Bruce Ferguson
Journal:  Eur J Cardiothorac Surg       Date:  2002-07       Impact factor: 4.191

4.  Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease.

Authors:  K K Wu; N Aleksic; C Ahn; E Boerwinkle; A R Folsom; H Juneja
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

5.  Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death.

Authors:  R B Zotz; M Klein; H P Dauben; C Moser; E Gams; R E Scharf
Journal:  Thromb Haemost       Date:  2000-03       Impact factor: 5.249

6.  Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery.

Authors:  Jochen D Muehlschlegel; Kuang-Yu Liu; Tjörvi E Perry; Amanda A Fox; Charles D Collard; Stanton K Shernan; Simon C Body
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

7.  Gene expression profile after cardiopulmonary bypass and cardioplegic arrest.

Authors:  Marc Ruel; Cesario Bianchi; Tanveer A Khan; Shu Xu; John R Liddicoat; Pierre Voisine; Eugenio Araujo; Helen Lyon; Isaac S Kohane; Towia A Libermann; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

8.  Expression of thrombomodulin on monocytes is associated with early outcomes in patients with coronary artery bypass graft surgery.

Authors:  Chien-Sung Tsai; Yi-Ting Tsai; Chih-Yuan Lin; Tso-Chou Lin; Go-Shine Huang; Gou-Jehg Hong; Feng-Yen Lin
Journal:  Shock       Date:  2010-07       Impact factor: 3.454

9.  Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery.

Authors:  Henry Völzke; Julia Engel; Volker Kleine; Christian Schwahn; Johannes B Dahm; Lothar Eckel; Rainer Rettig
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

10.  Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.

Authors:  P E Morange; C Simon; M C Alessi; G Luc; D Arveiler; J Ferrieres; P Amouyel; A Evans; P Ducimetiere; I Juhan-Vague
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

View more
  19 in total

1.  A genome-wide association study of variations in maternal cardiometabolic genes and risk of placental abruption.

Authors:  Amy Moore; Daniel A Enquobahrie; Sixto E Sanchez; Cande V Ananth; Percy N Pacora; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

Review 2.  Genetics of coronary artery disease.

Authors:  Wolfgang Lieb; Ramachandran S Vasan
Journal:  Circulation       Date:  2013-09-03       Impact factor: 29.690

3.  G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving β-blockers.

Authors:  Mihai V Podgoreanu; Joseph P Mathew; Miklos D Kertai; Yen-Wei Li; Yi-Ju Li; Svati H Shah; William E Kraus; Manuel L Fontes; Mark Stafford-Smith; Mark F Newman
Journal:  Circ Cardiovasc Genet       Date:  2014-07-21

4.  Interleukin-1β gene variants are associated with QTc interval prolongation following cardiac surgery: a prospective observational study.

Authors:  Miklos D Kertai; Yunqi Ji; Yi-Ju Li; Joseph P Mathew; James P Daubert; Mihai V Podgoreanu
Journal:  Can J Anaesth       Date:  2016-02-08       Impact factor: 5.063

5.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

6.  Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: a preliminary study.

Authors:  Viktória Kovacs; Balazs Gasz; Borbala Balatonyi; Luca Jaromi; Peter Kisfali; Balazs Borsiczky; Gabor Jancso; Nandor Marczin; Sandor Szabados; Bela Melegh; Alotti Nasri; Elisabeth Roth
Journal:  Mol Cell Biochem       Date:  2014-01-17       Impact factor: 3.396

7.  Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.

Authors:  Abrar Ahmad; Kristina Sundquist; Bengt Zöller; Peter J Svensson; Jan Sundquist; Ashfaque A Memon
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

8.  Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting Surgery.

Authors:  Miklos D Kertai; Shan Zhou; Jörn A Karhausen; Mary Cooter; Edmund Jooste; Yi-Ju Li; William D White; Solomon Aronson; Mihai V Podgoreanu; Jeffrey Gaca; Ian J Welsby; Jerrold H Levy; Mark Stafford-Smith; Joseph P Mathew; Manuel L Fontes
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

9.  A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Authors:  Haruka Nomoto; Akiyoshi Takami; J Luis Espinoza; Keitaro Matsuo; Shohei Mizuno; Makoto Onizuka; Koichi Kashiwase; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Noriko Doki; Koichi Miyamura; Takehiko Mori; Shinji Nakao; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2015-08-06       Impact factor: 2.490

10.  COMT-Val158Met-polymorphism is not a risk factor for acute kidney injury after cardiac surgery.

Authors:  Matthias Kornek; Marcus-André Deutsch; Stefan Eichhorn; Harald Lahm; Stefan Wagenpfeil; Markus Krane; Ruediger Lange; Johannes Boehm
Journal:  Dis Markers       Date:  2013-08-07       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.